Oligodendrocytes: biology and pathology
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
Oligodendrocytes are the myelinating cells of the central nervous system (CNS). They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons. Due to this complex differentiation program, and due to their unique metabolism/physiology, oligodendrocytes count among the most vulnerable cells of the CNS. In this review, we first describe the different steps eventually culminating in the formation of mature oligodendrocytes and myelin sheaths, as they were revealed by studies in rodents. We will then show differences and similarities of human oligodendrocyte development. Finally, we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases, and we will reveal the different principles leading to the restoration of myelin sheaths or to a failure to do so.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20](https://figures.cochat.ai/paper-figures/777f35f33b804c4caf0983c7191aaa36/oligodendrocytes-biology-and-pathology-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, module 14 was enriched in genes involved in myelination49 and blood-brain barrier,50 consistent with the high enrichment of oligodendrocyte populations in the fiber tracts, and indicated blood-brain barrier changes in the thalamus.”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes have a high metabolic rate and must produce large amounts of membranes and protein, particularly during myelination (Bradl & Lassmann, 2010).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Bradl & Lassmann, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,090
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Ruiter, A. M., Meilof, J. F., Somanje-Bolweg, R. R. J., van Gorsel, E., & Kalkers, N. F. (2017) · Case Reports in Neurology · doi:10.1159/000455942 · Cited by 1,762
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Interneuron Migration from Basal Forebrain to Neocortex: Dependence on Dlx Genes
Anderson, S. A., Eisenstat, D. D., Shi, L., & Rubenstein, J. L. R. (1997) · Science · doi:10.1126/science.278.5337.474 · Cited by 1,462
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citation
Research works printed but not linked: 1
- Schlesinger H Zur Frage der akuten Multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter Arb Neurol Inst (Wien) 1909 17 410 432
Cited by
Items 101–200 of 943
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
Arotcarena, M.-L., Bourdenx, M., Dutheil, N., Thiolat, M.-L., Doudnikoff, E., Dovero, S., Ballabio, A., Fernagut, P.-O., Meissner, W. G., Bezard, E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129719 · Cited by 84
Raffaele, S., Boccazzi, M., & Fumagalli, M. (2021) · Cells · doi:10.3390/cells10030565 · Cited by 80
“The OPC maturation process comprises a complex sequence of events that can be simplified as follows: migration and proliferation of OPCs, differentiation of OPCs into myelinating OLs, initiation of membrane outgrowth and axonal wrapping, and rapid expansion of the myelin sheath and node formation [25,26].”
BackgroundAcs, P., Selak, M. A., Komoly, S., & Kalman, B. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.012 · Cited by 84
“OL death associated with mitochondrial damage is described as a dying back oligodendrocytopathy in MS (Bradl and Lassmann, 2010) and is indicated by the selective loss of the myelin associated glycoprotein (MAG) (Aboul-Enein et al.”
BackgroundWu, M., Xu, L., Wang, Y., Zhou, N., Zhen, F., Zhang, Y., Qu, X., Fan, H., Liu, S., Chen, Y., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.014 · Cited by 90
Livesey, M. R., Magnani, D., Cleary, E. M., Vasistha, N. A., James, O. T., Selvaraj, B. T., Burr, K., Story, D., Shaw, C. E., Kind, P. C., et al. (2016) · Stem Cells · doi:10.1002/stem.2273 · Cited by 81
Carlyle, B. C., Duque, A., Kitchen, R. R., Bordner, K. A., Coman, D., Doolittle, E., Papademetris, X., Hyder, F., Taylor, J. R., & Simen, A. A. (2012) · Development and Psychopathology · doi:10.1017/s095457941200079x · Cited by 80
“Inparticular, genes characteristically expressed by mature, myelinating oligodendrocytes such as Mag, Mbp, Mog, Omg, and Plp1 were found to be downregulated by RNA sequencing (Bradl & Lassmann, 2010; Dugas, Tai, Speed, Ngai, & Barres, 2006).”
BackgroundRamesh, G., Benge, S., Pahar, B., & Philipp, M. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-72 · Cited by 79
“As oligodendrocytes are vital for the survival and optimum function of neurons [91], oligodendrocyte damage could contribute to neuronal dysfunction and death and result in the impairment of CNS functions that are seen in patients with LNB.”
BackgroundMadeira, A., Burgelin, I., Perron, H., Curtin, F., Lang, A. B., & Faucard, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.006 · Cited by 87
“OPC are the non myelinating precursors of mature myelinating oligodendrocytes, which are crucial for nerve conduction in the CNS (Bradl and Lassmann, 2010).”
Experimental necrotizing enterocolitis induces neuroinflammation in the neonatal brain
Biouss, G., Antounians, L., Li, B., O’Connell, J. S., Seo, S., Catania, V. D., Guadagno, J., Rahman, A., Zani‐Ruttenstock, E., Svergun, N., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1481-9 · Cited by 85
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
Matejuk, A., Vandenbark, A. A., & Offner, H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.672455 · Cited by 78
“Oligodendrocytes are the most susceptible cells of the CNS, and mainly due to oxidative damage and their own high metabolic speed and vast oxygen usage, they needed to produce a bulk of lipids (108).”
BackgroundBisphenol-A Impairs Myelination Potential During Development in the Hippocampus of the Rat Brain
Tiwari, S. K., Agarwal, S., Chauhan, L. K. S., Mishra, V. N., & Chaturvedi, R. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8817-3 · Cited by 87
Li, J., & Yao, Z. (2012) · Molecular Neurobiology · doi:10.1007/s12035-011-8231-z · Cited by 86
“Apart from the different subclasses of OLs, which are derived from multiple sources and different OPC lines that compete with each other during spinal cord and brain development, and the technological reasons [36], the results also indicate that the different mechanisms of action of Fig.”
Loss of Branched O-Mannosyl Glycans in Astrocytes Accelerates Remyelination
Kanekiyo, K., Inamori, K.-I., Kitazume, S., Sato, K., Maeda, J., Higuchi, M., Kizuka, Y., Korekane, H., Matsuo, I., Honke, K., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3137-12.2013 · Cited by 78
“Since oligodendrocytes are particularly vulnerable to oxidative damage and mitochondrial injury (Bradl and Lassmann, 2010), cuprizone administration initially causes metabolic stress in these cells (Torkildsen et al., 2008).”
BackgroundWellman, S. M., Li, L., Yaxiaer, Y., McNamara, I., & Kozai, T. D. Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00493 · Cited by 87
“However, as energy-demanding cells, oligodendrocytes require high metabolic needs in order to produce and maintain the amount of myelin needed to support the central nervous system (McTigue and Tripathi, 2008; Bradl and Lassmann, 2010; Snaidero and Simons, 2017).”
BackgroundRegulation of oligodendrocyte precursor migration during development, in adulthood and in pathology
de Castro, F., Bribián, A., & Ortega, M. C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1365-6 · Cited by 93
“2b); (2) the activated OPCs then respond to mitogens and pro-migratory factors to populate demyelinated areas; and (3) the recruited OPCs start to differentiate into remyelinating oligodendrocytes [122, 124, 125].”
BackgroundMiller, E. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_17 · Cited by 92
Tiberi, M., & Chiurchiù, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673549 · Cited by 83
Lieblein‐Boff, J. C., Johnson, E. J., Kennedy, A. D., Lai, C., & Kuchan, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136904 · Cited by 79
“This is consistent with the notion that lutein supports myelination during development as oligodendrocytes require extremely high metabolic rates during peak myelination [47].”
ResultNeonatal Hyperoxia Exposure Disrupts Axon–Oligodendrocyte Integrity in the Subcortical White Matter
Ritter, J., Schmitz, T., Chew, L., Bührer, C., Möbius, W., Zonouzi, M., & Gallo, V. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5528-12.2013 · Cited by 80
“The preterm period in humans, and early postnatal development in rodents, is a time of active oligodendrogenesis, myelination, and axonal organization in the developing subcortical WM (Baumann and Pham-Dinh, 2001; Craig et al., 2003; Poliak and Peles, 2003; Bradl and Lassmann, 2010).”
BackgroundKhattar, N., Triebswetter, C., Kiely, M., Ferrucci, L., Resnick, S. M., Spencer, R. G. S., & Bouhrara, M. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118267 · Cited by 81
Hohnholt, M. C., Geppert, M., & Dringen, R. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.06.052 · Cited by 85
Hartlieb, T., Winkler, P., Coras, R., Pieper, T., Holthausen, H., Blümcke, I., Staudt, M., & Kudernatsch, M. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.07.009 · Cited by 75
Neuron-astrocyte omnidirectional signaling in neurological health and disease
Pathak, D., & Sriram, K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1169320 · Cited by 77
“Bradl and Lassmann (2010) and Oberheim et al.”
Rodríguez‐Cruces, R., & Concha, L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-4292.2015.02.06 · Cited by 88
“Overall myelin content can be reduced by decreasing its production, increasing its degradation, or reducing the number of myelinated axons (116), with the latter being the most likely in patients with TLE.”
BackgroundBrain Metastasis Organotropism
Yuzhalin, A. E., & Yu, D. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037242 · Cited by 75
Leoni, V., Nury, T., Véjux, A., Zarrouk, A., Caccia, C., Debbabi, M., Fromont, A., Sghaier, R., Moreau, T., & Lizard, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.029 · Cited by 72
Flygt, J., Gumucio, A., Ingelsson, M., Skoglund, K., Holm, J., Alafuzoff, I. I., & Marklund, N. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw025 · Cited by 76
“factorial, including growth factors and inflammatory signals (23, 79, 80).”
BackgroundAdult brain aging investigated using BMC-mcDESPOT–based myelin water fraction imaging
Bouhrara, M., Rejimon, A. C., Cortina, L. E., Khattar, N., Bergeron, C. M., Ferrucci, L., Resnick, S. M., & Spencer, R. G. S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.003 · Cited by 67
“Aside from potential direct damage, these insults can lead to loss of oligodendrocytes or impairment of their myelin synthetic capacity, resulting in deficits in myelin maintenance and repair during turnover, or frank demyelination (Bradl and Lassmann, 2010; Domingues et al., 2016).”
BackgroundQuan, L., Uyeda, A., & Muramatsu, R. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00193-y · Cited by 83
“proteoglycan neuron-glial antigen 2 (NG2), are the main dynamic, proliferative cells within the adult CNS [4].”
BackgroundTraumatic Brain Injury: An Age-Dependent View of Post-Traumatic Neuroinflammation and Its Treatment
Delage, C., Taib, T., Mamma, C., Lerouet, D., & Besson, V. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101624 · Cited by 75
“However, oligodendrocytes are highly vulnerable to oxidative stress, excitotoxicity and hypoxia consecutive to TBI primary brain damages, which promotes their apoptosis [22,86,87].”
BackgroundmiR-708-5p: a microRNA with emerging roles in cancer
Monteleone, N. J., & Lutz, C. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19772 · Cited by 70
“Astrocytes are responsible for supporting endothelial cell homeostasis, neuronal function, and response to injury, while oligodendrocytes insulate axons through creation and maintenance of the myelin sheath [135, 136].”
BackgroundMotion sickness susceptibility fluctuates through the menstrual cycle.
Golding, J. F., Kadzere, P., & Gresty, M. A. (2005) · PubMed · Cited by 97
Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor
Gupta, S., Singh, A. K., Prajapati, K. S., Kushwaha, P. P., Shuaib, M., & Kumar, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.015 · Cited by 63
Bordner, K. A., George, E. D., Carlyle, B. C., Duque, A., Kitchen, R. R., Lam, T. T., Colangelo, C. M., Stone, K. L., Abbott, T. B., Mane, S. M., et al. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00018 · Cited by 65
“Methylation within approximately −400 to +200 nt of the transcription start site was determined using bisulfite conversion, followed by PCR, base-specific cleavage, and MALDI-TOF mass spectrometry (Sequenom Inc).”
BackgroundMethodInfluentialIL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria
Reverchon, F., Mortaud, S., Sivoyon, M., Maillet, I., Laugeray, A., Palomo, J., Montécot, C., Herzine, A., Même, S., Même, W., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006322 · Cited by 74
Pathophysiology of Lipid Droplets in Neuroglia
Smolič, T., Zorec, R., & Vardjan, N. (2021) · Antioxidants · doi:10.3390/antiox11010022 · Cited by 78
Rolyan, H., Tyurina, Y. Y., Hernandez, M., Amoscato, A. A., Sparvero, L. J., Nmezi, B., Lu, Y., Estecio, M. R., Lin, K., Chen, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1668-15.2015 · Cited by 73
“Oligodendrocyte membranes are highly enriched in lipids (Bradl and Lassmann, 2010; Chrast et al., 2011).”
BackgroundSystemic inflammation, neuroinflammation and perioperative neurocognitive disorders
Jia, S., Yang, H., Huang, F., & Fan, W. (2023) · Inflammation Research · doi:10.1007/s00011-023-01792-2 · Cited by 71
“They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons [135].”
Ortega, M. C., Cases, O., Merchán, P., Kozyraki, R., Clemente, D., & de Castro, F. (2012) · Glia · doi:10.1002/glia.22316 · Cited by 62
“…is not random but rather their movement is directed by specific combinations of molecular cues (de Castro and Bribi an, 2005; Miller, 2002) following precise routes of migration characteristic to each CNS region (Bradl and Lassmann, 2010; Garc ıa-L opez and Mart ınez, 2010; Olivier et al., 2001).”
BackgroundInfluentialFerrer, I. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.07.004 · Cited by 62
Crosstalk of Astrocytes and Other Cells during Ischemic Stroke
He, T., Yang, G., & Zhang, Z. (2022) · Life · doi:10.3390/life12060910 · Cited by 75
“New myelinating oligodendrocytes are necessary for functional recovery [201].”
BackgroundLin, Y., Jamison, S., & Lin, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036408 · Cited by 65
“Oligodendrocytes are considered to be the target of immune attacks in immune-mediated demyelinating diseases [38].”
BackgroundNeuroglia in ageing and disease
Verkhratsky, A., Rodriguez, J. J., & Parpura, V. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1814-z · Cited by 68
“The oligodendrocytes are myelinating cells of the brain that are present both in the grey and white matter (Bradl and Lassmann 2010; Emery 2010).”
Newville, J., Valenzuela, C. F., Li, L., Jantzie, L. L., & Cunningham, L. A. (2017) · Glia · doi:10.1002/glia.23164 · Cited by 73
Lai, B., Feng, B., Che, M., Wang, L., Cai, S., Huang, M., Gu, H., Jiang, B., Ling, E., Li, M., et al. (2018) · Advanced Science · doi:10.1002/advs.201800261 · Cited by 66
A hypothesis for the role of axon demyelination in seizure generation
de Curtis, M., Garbelli, R., & Uva, L. (2021) · Epilepsia · doi:10.1111/epi.16824 · Cited by 65
“The summarized findings reviewed in the previous sections demonstrate that (1) human and experimental focal epilepsies are associated with WM demyelination and reduction of ODCs, (2) demyelinated axons in both the WM and GM are hyperexcitable, (3) ectopic APs can be generated in demyelinated axons, (4) altered K+ buff…”
BackgroundThe Role of Glial Cell Senescence in Alzheimer's Disease
Alshaebi, F., Sciortino, A., & Kayed, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70051 · Cited by 60
“Oligodendrocyte precursor cells (OPCs), which possess the highest proliferation rate amongst glial cells, generate new oligodendrocytes to restore myelin in demyelinated areas (Bradl and Lassmann 2010; Wang et al. 2020; Young et al. 2013).”
Brain structure, working memory and response inhibition in childhood leukemia survivors
van der Plas, E., Schachar, R. J., Hitzler, J., Crosbie, J., Guger, S. L., Spiegler, B. J., Ito, S., & Nieman, B. J. (2017) · Brain and Behavior · doi:10.1002/brb3.621 · Cited by 59
“…(e) 0 20% lp C R V ol um e (1 03 m m 3 ) 2.0 3.0 N or m al iz ed V ol um e 0.9 1.0 7.5 10.0 12.5 15.0 17.5 lCCG lsLF lpCR lALIC total CC (2.5) (6.9) (3.1) (2.1) (26) (100) (55) (52) (27) Controls Standard-Risk-ALL High-Risk-ALL Controls ALL survivors (b) myelination (Bradl & Lassmann, 2010).”
InfluentialShepherd, C., Liu, J. Y. W., Goc, J., Martinian, L., Jacques, T. S., Sisodiya, S. M., & Thom, M. (2013) · Epilepsia · doi:10.1111/epi.12143 · Cited by 61
“Their differentiation and maturation is shown by sequential expression of lineage markers from PDGFa/NG2 in early OPC to NogoA and MBP in mature OL (Jakovcevski et al., 2009; Bradl & Lassmann, 2010; Muhlebner et al., 2012).”
BackgroundHu, Y., Lee, X., Ji, B., Guckian, K. M., Apicco, D. J., Pepinsky, R. B., Miller, R. H., & Mi, S. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.06.007 · Cited by 62
Stroh, L. J., Maginnis, M. S., Blaum, B. S., Nelson, C. D. S., Neu, U., Gee, G. V., O’Hara, B. A., Motamedi, N., DiMaio, D., Atwood, W. J., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00489-15 · Cited by 62
Abbas, W. A., Ibrahim, M. E., Elnaggar, M. A., Abass, W. A., Abdullah, I. H., Awad, B. I., & Allam, N. K. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01074 · Cited by 59
Klose, J., Pahl, M., Bartmann, K., Bendt, F., Blum, J., Dolde, X., Förster, N., Holzer, A.-K., Hübenthal, U., Keßel, H. E., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09603-2 · Cited by 58
“They have a high energy and iron demand, are dependent on functional lipid metabolism, and their development and function are highly regulated by different hormones and growth factors (Bradl and Lassmann 2010; Volpe et al. 2011; Marinelli et al. 2016).”
BackgroundResultMaginnis, M. S., Stroh, L. J., Gee, G. V., O’Hara, B. A., Derdowski, A., Stehle, T., & Atwood, W. J. (2013) · mBio · doi:10.1128/mbio.00247-13 · Cited by 57
NF-κB Activation Protects Oligodendrocytes against Inflammation
Stone, S., Jamison, S., Yue, Y., Durose, W. W., Schmidt‐Ullrich, R., & Lin, W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1608-17.2017 · Cited by 63
“Death of (re)myelinating oligodendrocytes induced by inflammation contributes to remyelination failure in MS (Bradl and Lassmann, 2010; Watzlawik et al., 2010; Stone and Lin, 2015).”
BackgroundInfluentialLu, C., Dong, L., Zhou, H., Li, Q., Huang, G., Bai, S. J., & Liao, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-22452-0 · Cited by 57
Na+-dependent transporters: The backbone of astroglial homeostatic function
Verkhratsky, A., & Rose, C. R. (2020) · Cell Calcium · doi:10.1016/j.ceca.2019.102136 · Cited by 57
“The raison d’etre of neuroglia and their foremost function is preservation of the homeostasis of the CNS, support of neuronal function, myelination of axons, assistance in synaptogenesis and protection of the nervous tissue (for further details and references see [1-13]).”
BackgroundLan, M., Tang, X., Zhang, J., & Yao, Z. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0033 · Cited by 58
“Due to the complex differentiation program and the unique metabolism and physiology, OLs are one kind of the most vulnerable cells in the CNS (Bradl and Lassmann, 2010).”
BackgroundDestination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
Joshi, C. R., Labhasetwar, V., & Ghorpade, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9724-3 · Cited by 55
“The underlying pathways linked to oligodendrocyte loss consist of oxidative and mitochondrial stress (Bradl and Lassmann 2010), proinflammatory cytokine signaling, free radicals, and complement-facilitated injury (Merrill and Scolding 1999).”
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
Zárate-López, D., Torres-Chávez, A. L., Gálvez‐Contreras, A. Y., & González-Pérez, Ó. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231003121513 · Cited by 72
“They facilitate neuronal transmission and provide trophic and metabolic factors [292].”
BackgroundBrain-Derived Neurotrophic Factor, Nociception, and Pain
Merighi, A. (2024) · Biomolecules · doi:10.3390/biom14050539 · Cited by 62
Pang, Y., Zheng, B., Kimberly, S. L., Cai, Z., Rhodes, P. G., & Lin, R. C. S. (2012) · Brain and Behavior · doi:10.1002/brb3.33 · Cited by 53
Nellessen, A., Nyamoya, S., Zendedel, A., Slowik, A., Wruck, C. J., Beyer, C., Fragoulis, A., & Clarner, T. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00488-z · Cited by 59
“The combination of these cellular properties renders oligodendrocytes particularly vulnerable to disturbances in energy metabolism and oxidative dysbalance (Bradl and Lassmann 2010).”
BackgroundTargeting with nanoparticles for the therapeutic treatment of brain diseases
Jin, G., Chakraborty, A., Lee, J., Knowles, J. C., & Kim, H. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731419897460 · Cited by 54
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021) · Life · doi:10.3390/life11030229 · Cited by 55
“Oligodendrocytes (OLs) are derived from oligodendrocyte precursor cells (OPCs) in a highly regulated process [171].”
BackgroundMyelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities
Huang, Z., Jordan, J. D., & Zhang, Q. (2023) · Aging and Disease · doi:10.14336/ad.2023.0628 · Cited by 62
“Oligodendrocytes are specialized myelin-forming cells in the CNS, which represent the second major glial cell type in the mammalian CNS [10].”
BackgroundBhatt, M., Sharma, M., & Das, B. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01519-9 · Cited by 68
Oligodendroglial excitability mediated by glutamatergic inputs and Nav1.2 activation
Berret, E., Barron, T., Xu, J., Debner, E. K., Kim, E. J., & Kim, J. H. (2017) · Nature Communications · doi:10.1038/s41467-017-00688-0 · Cited by 56
Shaaban, S., Fasseur, D., Andreoletti, P., Zarrouk, A., Richard, P., Negm, A., Manolikakes, G., Jacob, C., & Cherkaoui‐Malki, M. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.05.019 · Cited by 54
Cell Signaling in Neuronal Stem Cells
Quiroz, E. N., Quiroz, R. N., Ahmad, M., Escorcia, L. G., Camacho, J. L. V., Fernandez-Ponce, C. M., & Aroca, G. (2018) · Cells · doi:10.3390/cells7070075 · Cited by 57
“In this case, competition for limiting quantities of growth factors like platelet-derived growth factor (PDGF) might be a determining factor for winning the competition [179].”
BackgroundWong, M. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9289-6 · Cited by 54
Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Nolan, M., Scott, C., Pallebage‐Gamarallage, M. M., Lunn, D., Carpenter, K., McDonough, E., Meyer, D. E., Kaanumalle, S., Santamaría-Pang, A., Turner, M. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00961-2 · Cited by 58
Cell fate control in the developing central nervous system
Guérout, N., Li, X., & Barnabé‐Heider, F. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.10.003 · Cited by 67
Winters, J. J., Ferguson, C. J., Lenk, G. M., Giger-Mateeva, V. I., Shrager, P., Meisler, M. H., & Giger, R. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1482-11.2011 · Cited by 52
“Normal generation and distribution of OPCs in Fig4 / mice Failure in the OL lineage to produce sufficient numbers of myelinating MAG OLs may be a reflection of insufficient numbers of OPCs, impaired cell migration, arrest in OL maturation, or cell death (Barres and Raff, 1994; Bradl and Lassmann, 2010).”
BackgroundFlygt, J., Ruscher, K., Norberg, A., Mir, A. K., Gram, H., Clausen, F., & Marklund, N. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5660 · Cited by 60
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 62
“Oligodendrocytes are responsible for the production of myelin [619] that surrounds the neuronal processes, mediates the transmission of electric signals between neurons and provides a neurotrophic support [620–623].”
BackgroundAdaptive structural changes in the motor cortex and white matter in Parkinson’s disease
Fu, Y., Zhou, L., Li, H., Hsiao, J.-H. T., Li, B., Tanglay, O., Auwyang, A. D., Wang, E., Feng, J., Kim, W. S., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02488-3 · Cited by 54
Cho, A.-N., Jin, Y., Kim, S., Kumar, S., Shin, H., Kang, H.-C., & Cho, S.-W. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03242 · Cited by 51
Sharma, K., Singh, J., Pillai, P. P., & Frost, E. E. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0597-3 · Cited by 56
“Oligodendrocyte development progress through the several phases includes oligodendrocyte precursor, immature and to finallymature myelinating oligodendrocytes (Baumann and Pham-Dinh 2001; Bradl and Lassmann 2010).”
BackgroundHanrieder, J., Wicher, G., Bergquist, J., Andersson, M., & Svenningsen, Å. F. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5043-y · Cited by 64
Hallmarks of neurodegenerative disease: A systems pharmacology perspective
Bloomingdale, P., Karelina, T., Ramakrishnan, V., Bakshi, S., Véronneau‐Veilleux, F., Moye, M., Sekiguchi, K., Meno‐Tetang, G. M. L., Mohan, A., Maithreye, R., et al. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12852 · Cited by 67
Glioblastoma Multiforme—A Look at the Past and a Glance at the Future
King, J. L., & Benhabbour, S. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071053 · Cited by 54
“There are three different types of gliomas: ependymomas which arise from glial cells in the epithelial lining of the brain and spinal cord, oligodendrogliomas which originate from oligodendrocytes, and astrocytomas which develop from astrocytes [3,4].”
BackgroundZimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
“They undergo a complex and precisely timed cycle of proliferation, migration, and differentiation to finally generate myelin by concentrically wrapping axons with multilamellar sheets of plasma membrane consisting of specific proteins and lipids (139).”
Lin, Y., Huang, G., Jamison, S., Li, J., Harding, H. P., Ron, D., & Lin, W. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.009 · Cited by 52
“Thus, it is unlikely that AP20187 treatment promotes remyelination in the EAE demyelinated lesions of PLP/Fv2E-PERK mice by altering the inflammatory response. in the CNS of PLP/Fv2E-PERK mice undergoing EAE.”
BackgroundInfluentialVaes, J. E. G., Vink, M., de Theije, C. G. M., Hoebeek, F. E., Benders, M. J. N. L., & Nijboer, C. H. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00540 · Cited by 50
“Zhang et al. (2016) studied the direct effect of rat ectodermal MSCs (derived from the neural crest) in both a non-contact (transwell) and cell-cell contact co-culture with OPCs.”
BackgroundInfluentialCadherin-Based Transsynaptic Networks in Establishing and Modifying Neural Connectivity
Friedman, L. G., Benson, D. L., & Huntley, G. W. (2015) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.025 · Cited by 53
“Myelination is highly regulated by molecular cues that control specific axon– oligodendrocyte interactions (Bradl & Lassmann, 2010).”
BackgroundOrtega, M. C., Bribián, A., Peregrín, S., Gil, M., Marín, Ó., & de Castro, F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.03.015 · Cited by 66
“…and their subsequent masking for the observer cannot be excluded, it has been suggested that this first wave of OPCs is an evolutionary relic (primitive source of OPCs) or reflects the turnover of oligodendrocytes due to environmental influences (Bradl and Lassmann, 2010; Richardson et al., 2006).”
BackgroundInfluentialDulămea, A. O. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.221146 · Cited by 56
“To populate demyelinated areas, the recruited OPCs start to differentiate into remyelinating OLs (Franklin and Ffrench-Constant, 2008; Bradl and Lassmann, 2010).”
BackgroundTandon, A., Singh, S. J., Gupta, M., Singh, N., Shankar, J., Arjaria, N., Goyal, S., & Chaturvedi, R. K. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122052 · Cited by 49
Wellman, S. M., Guzman, K., Stieger, K. C., Brink, L. E., Sridhar, S., Dubaniewicz, M. T., Li, L., Cambi, F., & Kozai, T. D. Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119842 · Cited by 47
“As a result, reductions in intracellular energy, accumulation of reactive oxidative species, and inherently low antioxidant levels in oligodendrocytes can lead to cellular apoptosis following cuprizone administration [30, 59].”
BackgroundTiane, A., Schepers, M., Riemens, R. J. M., Rombaut, B., Vandormael, P., Somers, V. A., Prickaerts, J., Hellings, N., van den Hove, D., & Vanmierlo, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03927-2 · Cited by 50
Zhang, L., Zhou, Y., Yang, Z., Jiang, L., Yan, X., Zhu, W., Shen, Y., Wang, B., Li, J., & Song, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03334-5 · Cited by 56
“Oligodendrocyte can produce myelin—a multilayered membrane rich in lipids, particularly cholesterol—that wraps around the axon to facilitate rapid neural signal transmission [178].”
InfluentialJC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection
Maginnis, M. S., Nelson, C. D. S., & Atwood, W. J. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0272-4 · Cited by 46
“…(Houff et al. 1988; Dorries et al. 1994; Dubois et al. 1996; Dubois et al. 1997) where it infects glial cells critical for myelination: astrocytes and oligodendroctyes (Silverman and Rubinstein 1965; Zurhein and Chou 1965; Spiegel and Peles 2006; Sorensen et al. 2008; Bradl and Lassmann 2010).”
BackgroundVCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination
Miyamoto, Y., Torii, T., Tanoue, A., & Yamauchi, J. (2016) · Nature Communications · doi:10.1038/ncomms13478 · Cited by 45
Li, E., Zheng, Y., Cai, M., Lai, Q., Fang, G., Du, B., Shen, C., Zhang, Y., Wu, L., & Ding, M. (2022) · Epilepsia · doi:10.1111/epi.17315 · Cited by 46
Genetic approaches to study glial cells in the rodent brain
Pfrieger, F. W., & Slezak, M. (2012) · Glia · doi:10.1002/glia.22283 · Cited by 45
“The formation and maintenance of myelin imposes a heavy metabolic load on oligodendrocytes and therefore, these cells are highly vulnerable to pathologic conditions due to injury or disease (Bradl and Lassmann, 2010).”
BackgroundShared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies
Rohan, Z., Milenković, I., Lutz, M. I., Matěj, R., & Kovács, G. G. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw087 · Cited by 49
“Importantly, oligodendrocytes show specific reactions to various CNS diseases (5, 6).”
BackgroundToxin-Based Models to Investigate Demyelination and Remyelination
McMurran, C. E., Zhao, C., & Franklin, R. J. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_21 · Cited by 48
Du, B., Liu, X., Zheng, H., Fan, C., Liang, M., Lian, Y., Wei, Z., Zhang, Y., & Bi, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01247 · Cited by 47
“High-mobility group box 1 (HMGB1), also known as an alarmin protein, has been implicated as a critical factor involved in ischemia–reperfusion injury, mood disorder, cognitive impairment, and inflammation-related diseases in the CNS (Goldstein et al., 2006; Takata et al., 2012).”
BackgroundInfluentialStrategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
Enders, M., Heider, T., Ludwig, A., & Küerten, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051663 · Cited by 50
“Their main purpose is the formation of the myelin sheath [4,5], which is complex and requires different stimuli.”
Background
Metadata
- Authors
- Bradl, M., & Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Bradl, Monika
- Venue
- Acta Neuropathologica
- Published
- 2009-10-22
- Volume
- 119
- Issue
- 1
- Pages
- 37-53
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2799635
- OpenAlex
- W2018558728
- Cited by
- 933
- References
- 221
- Citations by year
- 2026: 66 · 2025: 67 · 2024: 85 · 2023: 69 · 2022: 74 · 2021: 84 · 2020: 61 · 2019: 72 · 2018: 50 · 2017: 46 · 2016: 44 · 2015: 39 · 2014: 41 · 2013: 51 · 2012: 28
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (P 19854)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oligodendrocytes, myelination, myelin sheath, oligodendrocyte lineage, oligodendrocyte differentiation, demyelination, demyelinating disease, central nervous system
- MeSH terms
- Animals, Central Nervous System, Central Nervous System Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Species Specificity, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.